Novo Nordisk

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Biopharma Dive
Minnesota
insulin
diabetes
PBMs
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
CP Wire
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
Novo Nordisk picks AstraZeneca executive to head biopharma business
Novo Nordisk picks AstraZeneca executive to head biopharma business
Yahoo/Reuters
Novo Nordisk
AstraZeneca
Ludovic Helfgott
Flag link:
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Endpoints
Eli Lilly
diabetes
Novo Nordisk
Ozempic
LY3298176
Trulicity
Flag link:
Novo to market ‘connected’ insulin pens next year
Novo to market ‘connected’ insulin pens next year
Pharmaforum
Novo Nordisk
insulin pen
devices
connected insulin pen
diabetes
Flag link:
Novo to create California stem cell therapy manufacturing site
Novo to create California stem cell therapy manufacturing site
Pharmaforum
Novo Nordisk
stem cells
drug manufacturing
California
Flag link:
On the heels of a global R&D reorganization, Novo Nordisk outlines 250 US job cuts
On the heels of a global R&D reorganization, Novo Nordisk outlines 250 US job cuts
Endpoints
Novo Nordisk
layoffs
reorganization
Flag link:
Novo Nordisk to Lay off 400 to Focus on Innovation
Novo Nordisk to Lay off 400 to Focus on Innovation
BioSpace
Novo Nordisk
R&D
layoffs
Denmark
China
Flag link:
Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production
Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production
Fierce Pharma
Pfizer
GSK
Novo Nordisk
Novartis
drug manufacturing
hurricanes
Flag link:
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Pharmaforum
Novo Nordisk
insulin
UK
Brexit
Flag link:
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in
Fierce Pharma
Novartis
Novo Nordisk
Pfizer
GSK
hurricanes
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Flag link:
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
CP Wire
Novo Nordisk
M&A
insulin
Ziylo
Flag link:
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
Novo Nordisk
M&A
Flag link:
Novo Nordisk's Pricing Pressures Aren't Going Away
Novo Nordisk's Pricing Pressures Aren't Going Away
Motley Fool
Novo Nordisk
earnings
drug pricing
Flag link:
Novo Nordisk sees lower US prices next year; second-quarter profit in line with forecasts
Novo Nordisk sees lower US prices next year; second-quarter profit in line with forecasts
CNBC
Novo Nordisk
earnings
drug prices
Flag link:
Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule
Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule
Drug Delivery Business News
Novo Nordisk
digital health
Flag link:
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Fierce Biotech
diabetes
Parkinson's Disease
GLP-1 agonist
AstraZeneca
Byetta
Bydureon
Novo Nordisk
Victoza
Ozempic
Eli Lilly
Trulicity
Peptron
Flag link:

Pages